Aurora Cannabis Inc.ACB.TO
Consumer Staples · Food, Beverage & Tobacco · TSX · Canada · auroramj.com
Aurora Cannabis Inc. is a Canadian integrated cannabis company that produces, distributes, and sells medical and consumer cannabis products in Canada and internationally. The company operates through wholly owned subsidiaries and strategic partnerships, offering premium cannabis products under multiple brands. Aurora is dual-listed on the Toronto Stock Exchange and NASDAQ.
Key ratios
FCF / Sales
-8.4%TTM
2025
-0.8%2024
-31.7%2023
-72.7%
Net margin
-22.5%TTM
2025
0.7%2024
-24.3%
ROA
-4.4%TTM
2025
0.6%2024
-2.8%
ROE
-15.5%TTM
2025
2.6%2024
-10.2%
Recent news
Aurora Cannabis Announces the Alberta Securities Commission has dismissed Curaleaf's Application and ruled in favour of the Company's At-the-Market Program
Aurora Cannabis Reaffirms Recommendation to Shareholders: REJECT Curaleaf's Revised Hostile Bid; Preserve Opportunities for Future Upside
Aurora Completes Major Expansion of European EU-GMP Manufacturing Facility, More Than Doubling Expected Annual Flower Output
Aurora Urges Shareholders to Take No Action to Revised Hostile Bid by Curaleaf as Formal Review Underway
Aurora Maintains Shareholder Recommendation to Take No Action at this Time as Curaleaf Has Yet to File Their Revised Hostile Bid
Aurora Cannabis Files Application with Alberta Securities Commission to Protect Company Shareholders Having Identified Several Deficiencies in Curaleaf's Hostile Bid Disclosure
Aurora Cannabis Provides Business Update; Accretive Acquisition of Safari Flower Company and Leading European Performance Expected to Fuel International Growth
Aurora Cannabis Refutes Curaleaf's Latest Attempt to Distract Shareholders From the Facts
Aurora Appoints Seasoned Biopharmaceutical Executive to Lead Commercial Acceleration of Global Medical Cannabis Business
Aurora Cannabis Urges Shareholders to REJECT Curaleaf's Hostile Bid, Warning that it is Inadequate, Undervalues Aurora and Puts Shareholder Value and Future Upside at Risk
Track ACB.TO in your journal
Save it to a watchlist, run a reverse DCF, and keep your notes on the company in one place. Free to start.
Figures are sourced from third parties and shown for research only. They may be delayed or incomplete, and nothing on this page is investment advice or a recommendation to buy or sell. Read the full disclaimer